To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in COMPASS Pathways plc by 121,682 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 3.52% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Alamar Biosciences by 26,092 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 1.59% of the total position.
      27Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 9,790 shares, the number of shares held decreased 2.73% compared to the previous period and now represents 3.94% of the total position.
      76Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 41,734 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 4.16% of the total position.
      8Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Generate Biomedicines by 33,726 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 1.03% of the total position.
      161Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Prime Medicine, Inc. by 204,820 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 1.35% of the total position.
      469Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 48,378 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 2.58% of the total position.
      347Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Eli Lilly by 1,716 shares, the number of shares held decreased 2.72% compared to the previous period and now represents 4.38% of the total position.
      15Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 130,042 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 2.45% of the total position.
      78Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·08-12 07:13
      ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 12,408 shares, the number of shares held decreased 2.74% compared to the previous period and now represents 4.47% of the total position.
      38Comment
      Report
    • empty
      No following yet
       
       
       
       

      Most Discussed